CORT - Corcept Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

CORT is currently covered by 5 analysts with an average price target of $119.8. This is a potential upside of $56.18 (88.31%) from yesterday's end of day stock price of $63.62.

Our record on Corcept Therapeutics covers 15 analysts since 2008; 5 cover it today. Of the 129 price targets those analysts set on CORT, 98 were reached (76%). The highest performance score on Corcept Therapeutics belongs to Joon Lee of Truist: 14.67, with 10 of 13 targets met in 168 days on average. The latest calls: David Amsellem of Piper Sandler raised the target to $173 from $165 with a Buy rating on 4 Nov 2026; Swayampakula Ramakanth of H.C. Wainwright kept the target at $165 with a Buy rating on 18 Sep 2026; Edward Nash of Canaccord raised the target to $161 from $135 with a Buy rating on 30 Jul 2026. Figures as of 18 Nov 2026.

Corcept Therapeutics's activity chart (see below) currently has 139 price targets and 129 ratings on display. The stock rating distribution of CORT is 84.62% BUY, 7.69% HOLD and 7.69% SELL.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 75.76% of the time, taking 241.92 days on average.

Highest price target for CORT is $173, Lowest price target is $50, average price target is $119.8.

Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 04-Nov-2026. First documented stock forecast 11-Mar-2015.

Currently out of the existing stock ratings of CORT, 22 are a BUY (84.62%), 2 are a HOLD (7.69%), 2 are a SELL (7.69%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-Apr-2023

$173

$109.38 (171.93%)

$165

18 days ago
(04-Nov-2026)

11/15 (73.33%)

$93.78 (118.38%)

109

Buy Since 06-Sep-2019

$165

$101.38 (159.35%)

$165

2 months 4 days ago
(18-Sep-2026)

29/38 (76.32%)

$54.71 (49.61%)

202

Buy Since 27-Jun-2022

$161

$97.38 (153.07%)

$135

3 months 23 days ago
(30-Jul-2026)

14/24 (58.33%)

$42.68 (36.07%)

233

Hold Since 27-Jul-2026

$50

$-13.62 (-21.41%)

3 months 26 days ago
(27-Jul-2026)

0/2 (0%)

$-41.12 (-45.13%)

Buy Since 03-Jan-2024

$50

$-13.62 (-21.41%)

$135

10 months 22 days ago
(31-Dec-2025)

10/13 (76.92%)

$15.2 (43.68%)

168

Show more analysts

Please expand the browser size to see the chart

What is CORT (Corcept Therapeutics) average time for price targets to be met?

On average it took 242 days for the stock forecasts to be reached, with an average price target met ratio of 75.76%.

Which analyst most recently updated their price target on CORT (Corcept Therapeutics)?

David Amsellem

Which analyst has the most public recommendations on CORT (Corcept Therapeutics)?

David Amsellem works at PIPER SANDLER and has 11 price targets and 10 ratings on CORT

Which analyst is the currently most bullish on CORT (Corcept Therapeutics)?

David Amsellem with the highest potential upside of $109.38

Which analyst is the currently most reserved on CORT (Corcept Therapeutics)?

Tazeen Ahmad with the lowest potential downside of -$57.62
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?